Typo - Thus not this*
"...Those epic deals in the £B's are always due to the perceived huge commercial potential."
But that I think is my point, pre clinical deals i.e. perceived huge commercial "potential", still go for $billions. Don't Scancell have an advantage/this increased potential here?
Just to add to my last post, a very key point, another key reason I stay invested is when you see the size of deals for mere pre-clinical drugs/ bio companies.
The reason I stay invested (rightly or wrongly), and the reason I add on the dips is that if I was a big pharma, I would definitely be looking at Scancell and their very impressive portfolio. So purely IMO I strongly believe there are multiple parties interested as we speak.
IMO If a big pharma was to buy out Scancell outright their portfolio would overnight become far more comprehensive and hugely promising. And just imagine the progress of development and trials with big pharma backing.
In fact as mentioned by others, Scancell has a portfolio that is arguably bigger and better that some medium/large pharma?
Yes, imagine being out of that just it before went stratospheric. You'd be crying into your cornflakes.
And yes the chart does have some striking similarities IMO.
Do you want to join? We all have cool embroidered leather jackets with "Team Ramp" written on the back, and a secret handshake.
Is it just me or do your posts make zero sense?
But yes I agree with your sentiment that they do need to be more forthcoming with news in general.
"Most of us underwater facing a huge delema". Bit of sweeping assumption that maxp? No?
Obviously I'm not happy with SP, not at all happy in fact,but can honestly say never felt more (paradoxically) at ease because of everything we know that is happening in the background.
For me personally IMO, it is a case of when the news comes not if.
Purely IMO, the Observer/Guardian interview has the feel of those that given to the Sahin's, and this is despite Scancell not having a commercial product yet. Impressive IMO.
https://www.theguardian.com/world/2020/nov/10/ugur-sahin-and-ozlem-tureci-german-dream-team-behind-vaccine
Https://uk.linkedin.com/company/kilburn-&-strode
"A great article about our inspirational client Lindy Durrant of Scancell Ltd. We’re deeply proud to have supported Scancell in its quest to find treatments for cancer by protecting its intellectual property since it was formed in 1997."
"‘Designing a vaccine that covers all cancers is hard’: biotech pioneer Lindy Durrant | Biotechnology industry | The Guardian
https://lnkd.in/gUBjzDmF
#biotech #intellectualproperty "
Scroll down the comments to see reference to the observer article. Can't say I recollect these solicitors in context of Scancell and their IP before.
If the price keeps dipping I keep buying... Sorry doomies :)
Burble RE your post, whre do NDA's come into this? I.e. why the need to publicise their wares in this new, polished and mainstream manner that they are doing of late?
3 x excellent posts this morning that summarise the situation. They should be stickied somewhere.
The SP movement at the moment is after all based on relatively low volume. I would say a lot of it is down to boredom,impatience i.e. the traders leaving for other opportunities perhaps?
And yes, no more proactive, straight to the newspapers it seems! As mentioned by crumbs the PR has moved up a notch and the company do not seemed concerned about appeasing AIM/investors/the share price. Hopefully for good reasons, which with trial progress you'd think it was good reasons.
...there was decent interest in buying at around 13:40/50. You could argue the dip was "mopped up"!? Although that will be too rampy for some though. But support at the 13 & a bit range perhaps?
And marginally more buys thean sells? Yet still down? Anyone?
Also, if it matters(?), I think that gap from way back on October 24th was actually closed today.
Is it just me or is the drop today a gap fill from way back on Oct 24th 2022?
....for me, because of the reason I mentioned previously.
Very good points bojo2020 & miavoce . There does seem to be a more shall we say professional tone about them.
The fact there hant been a Proactive interview etc shows they feel they don't need to appease inestors for whatever reason. However this doesn't help us investors as we are still in the dark.
But IMO with everything were are actually aware of going on in the background, upcoming news you'd think will be significant.
Also the way I look at it you don't attend Bio partnering conference without good reason.
I can only think of is NDA/deal/partnership related?